{"id":7408,"date":"2026-05-19T09:47:26","date_gmt":"2026-05-19T12:47:26","guid":{"rendered":"http:\/\/nahoranoticias.com\/?p=7408"},"modified":"2026-05-19T09:47:27","modified_gmt":"2026-05-19T12:47:27","slug":"brasil-tem-nova-opcao-de-tratamento-para-cancer-de-mama-mais-agressivo","status":"publish","type":"post","link":"https:\/\/nahoranoticias.com\/?p=7408","title":{"rendered":"Brasil tem nova op\u00e7\u00e3o de tratamento para c\u00e2ncer de mama mais agressivo"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Anvisa aprovou nova indica\u00e7\u00e3o de medicamento j\u00e1 usado no pa\u00eds<\/p>\n\n\n\n<figure class=\"wp-block-audio\"><audio controls src=\"https:\/\/tts-app.ebc.com.br\/media\/tts\/256916.mp3\"><\/audio><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta segunda-feira (18) uma nova indica\u00e7\u00e3o terap\u00eautica para o medicamento\u00a0Enhertu\u00a0(trastuzumabe\u00a0deruxtecana).\u00a0\u00a0<img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1689799&amp;o=node\"><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1689799&amp;o=node\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">J\u00e1 registrado no Brasil para o tratamento de\u00a0c\u00e2ncer de mama,\u00a0o medicamento passa a ser usado\u00a0em combina\u00e7\u00e3o com o\u00a0pertuzumabe\u00a0para o tratamento de primeira linha de pacientes\u00a0com c\u00e2ncer de mama HER2\u2011positivo (IHC 3+ ou ISH+). a indica\u00e7\u00e3o \u00e9 feita em duas situa\u00e7\u00f5es desse tipo de c\u00e2ncer:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Irressec\u00e1vel &#8211; do tipo que n\u00e3o pode ser removido completamente por cirurgia<\/li>\n\n\n\n<li>metast\u00e1tico &#8211;\u00a0quando a doen\u00e7a se\u00a0espalhou do local original para outras partes do corpo<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">O&nbsp;HER2\u2011positivo representa aproximadamente 20% dos casos de c\u00e2ncer de mama&nbsp;e est\u00e1 associado a&nbsp;um&nbsp;comportamento cl\u00ednico mais agressivo,&nbsp;com&nbsp;maior risco de progress\u00e3o da doen\u00e7a e pior evolu\u00e7\u00e3o da doen\u00e7a, sobretudo nos est\u00e1gios avan\u00e7ados ou metast\u00e1ticos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Apesar dos avan\u00e7os terap\u00eauticos, essa condi\u00e7\u00e3o permanece incur\u00e1vel, configurando&nbsp;um&nbsp;importante problema de sa\u00fade p\u00fablica.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">De acordo com a Anvisa, a nova indica\u00e7\u00e3o foi fundamenta em estudo que demonstrou melhora clinicamente relevante e estatisticamente significativa na sobrevida livre de progress\u00e3o.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Anvisa aprovou nova indica\u00e7\u00e3o de medicamento j\u00e1 usado no pa\u00eds Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou, nesta segunda-feira (18)&hellip;<\/p>\n","protected":false},"author":1,"featured_media":7410,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,11],"tags":[],"class_list":["post-7408","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ciencia-e-tecnologia","category-saude"],"_links":{"self":[{"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/posts\/7408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7408"}],"version-history":[{"count":1,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/posts\/7408\/revisions"}],"predecessor-version":[{"id":7411,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/posts\/7408\/revisions\/7411"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=\/wp\/v2\/media\/7410"}],"wp:attachment":[{"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nahoranoticias.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}